-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KaqTOa0cEu/iIlifbt3/wBZxwz+nGMln0TNmF6isjyKD3kAsaC6UXBIc/wCFaaSk ar78BfiGn9BDLvzFOdFXNQ== 0001005477-98-003366.txt : 20010524 0001005477-98-003366.hdr.sgml : 20010524 ACCESSION NUMBER: 0001005477-98-003366 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19981120 FILED AS OF DATE: 19981124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VISIBLE GENETICS INC CENTRAL INDEX KEY: 0001010819 STANDARD INDUSTRIAL CLASSIFICATION: 3826 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: SEC FILE NUMBER: 000-28550 FILM NUMBER: 98757841 BUSINESS ADDRESS: STREET 1: 700 BAY ST STREET 2: SUITE 1000 CITY: TORONTO ONTARIO CANA STATE: A6 BUSINESS PHONE: 2127025700 MAIL ADDRESS: STREET 1: 700 BAY ST STE 1000 STREET 2: TORONTO ONTARIO CANADA CITY: M5G 1Z6 6-K 1 FORM 6-K - - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Issuer PURSUANT to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Visible Genetics, Inc. ------------------------ (Exact name of Registrant) 700 Bay Street, Suite 1000, Toronto, ON, Canada M5G 1Z6 ------------------------------------------------------- (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F Form 20-F |X| Form 40-F |_| Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes |_| No |x| - - -------------------------------------------------------------------------------- VISIBLE GENETICS INC. On November 20, 1998, the Company issued a press release to announce the private placement of 1,528,989 Common Shares for aggregate gross proceeds of $15.1 million. Exhibit 1. Press release - "Visible Genetics Inc. Closes $15.1 Million Private Equity Financing" 2 SIGATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. VISIBLE GENETICS INC. Date: November 20, 1998 By: /s/ Jeffrey D. Sherman ---------------------------------- Jeffrey D. Sherman Vice President, Finance & C.F.O. 3 EX-1 2 PRESS RELEASE Exhibit 1 - - -------------------------------------------------------------------------------- For Immediate Release VISIBLE GENETICS INC. CLOSES $15.1 MILLION PRIVATE EQUITY FINANCING Toronto, Canada (November 20, 1998) Visible Genetics Inc. (Nasdaq: VGIN) announced today that it has closed a private placement of 1.53 million common shares at US$9.875 per share, for total proceeds of US$15.1 million. Cruttenden Roth Incorporated of Irvine, California served as sole placement agent for the offering, which was placed with US institutional investors. The per-share price represents an approximate 3% discount to Visible Genetics' average closing price over the 60 trading days prior to November 15, 1998, the date the offering was priced. Concurrent with the closing of the private placement, the Company filed a shelf registration statement with the Securities and Exchange Commission covering the shares issued in the private placement. Visible Genetics Inc. manufactures and markets high performance automated DNA sequencing systems and complete diagnostic kits for the analysis of genes linked to disease. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the Registration Statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. -----END PRIVACY-ENHANCED MESSAGE-----